Literature DB >> 11045856

Neurophysiological findings and drinking levels in high-alcohol-drinking (HAD) and low-alcohol-drinking (LAD) rats.

C J Slawecki1, M Betancourt, T K Li, C L Ehlers.   

Abstract

BACKGROUND: Specific neurophysiological profiles, such as reduced P300 amplitude or altered spectral power in the EEG, have been associated with a risk for alcoholism in several clinical populations. In certain rodent models, high versus low alcohol consumption is associated with similar neurophysiological differences. For example, alcohol-preferring (P) rats have increased spectral power and decreased P300 amplitudes compared with alcohol-nonpreferring (NP) rats. In the present study, the neurophysiological profiles of high-alcohol-drinking (HAD) and low-alcohol-drinking (LAD) rats were assessed (1) to determine if their electrophysiological profiles are similar to P and NP rats and (2) to examine the relationship of these neurophysiological indices to ethanol drinking.
METHODS: Ethanol-naive HAD and LAD rats were implanted with cortical and amygdalar recording electrodes. Baseline EEG and event-related potentials (ERPs) then were assessed. Subsequently, all rats were trained to self-administer ethanol by using a sucrose-substitution procedure.
RESULTS: Baseline EEG and ERP (i.e., pre-ethanol exposure) were assessed based on line (HAD versus LAD) and actual ethanol consumption (high drinkers versus low drinkers). At baseline, ethanol-naive HAD rats displayed significantly greater power in the cortical EEG and decreased amygdala N1 ERP amplitude compared with ethanol-naive LAD rats. Similar EEG and ERP profiles have been observed when P and NP rats are compared. No differences in P300 between lines were observed, but high-drinking rats, independent of line, had significantly decreased P300 amplitude in the amygdala compared with low-drinking rats.
CONCLUSIONS: These data suggest there are some similarities in EEG and ERP profiles of P and HAD rats compared with NP and LAD rats. Furthermore, the data suggest that decreased P300 amplitude in the amygdala is associated with increased limited access ethanol drinking.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11045856

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  8 in total

Review 1.  Pharmacogenetic studies of alcohol self-administration and withdrawal.

Authors:  John C Crabbe; Tamara J Phillips
Journal:  Psychopharmacology (Berl)       Date:  2003-10-09       Impact factor: 4.530

Review 2.  Mechanisms underlying sleep-wake disturbances in alcoholism: focus on the cholinergic pedunculopontine tegmentum.

Authors:  Clifford M Knapp; Domenic A Ciraulo; Subimal Datta
Journal:  Behav Brain Res       Date:  2014-08-20       Impact factor: 3.332

Review 3.  Human and laboratory rodent low response to alcohol: is better consilience possible?

Authors:  John C Crabbe; Richard L Bell; Cindy L Ehlers
Journal:  Addict Biol       Date:  2010-04       Impact factor: 4.280

Review 4.  Adolescent ethanol exposure: does it produce long-lasting electrophysiological effects?

Authors:  Cindy L Ehlers; José R Criado
Journal:  Alcohol       Date:  2010-02       Impact factor: 2.405

5.  Differential effects of acute alcohol on prepulse inhibition and event-related potentials in adolescent and adult Wistar rats.

Authors:  Jerry P Pian; Jose R Criado; Cindy L Ehlers
Journal:  Alcohol Clin Exp Res       Date:  2008-09-25       Impact factor: 3.455

6.  Binge drinking effects on EEG in young adult humans.

Authors:  Kelly E Courtney; John Polich
Journal:  Int J Environ Res Public Health       Date:  2010-05-10       Impact factor: 3.390

7.  Effects of adolescent ethanol exposure on sleep in adult rats.

Authors:  José R Criado; Derek N Wills; Brendan M Walker; Cindy L Ehlers
Journal:  Alcohol       Date:  2008-10-14       Impact factor: 2.405

8.  Proteomics and metabolomics analysis of hepatic mitochondrial metabolism in alcohol-preferring and non-preferring rats.

Authors:  Hao-Long Zeng; Qing Yang; Hongying Du; Huijun Li; Ying Shen; Taotao Liu; Xi Chen; Ghulam Mustafa Kamal; Qing Guan; Liming Cheng; Jie Wang; Fuqiang Xu
Journal:  Oncotarget       Date:  2017-10-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.